miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer
MicroRNAs (miRNAs) have been found to be dysregulated in prostate cancer (PCa). In this study, we investigated if miR-1207-3p is capable of distinguishing between indolent and aggressive PCa and if it contributes to explaining the disproportionate aggressiveness of PCa in men of African ancestry (mo...
Main Authors: | Dibash K. Das, Joseph R. Osborne, Hui-Yi Lin, Jong Y. Park, Olorunseun O. Ogunwobi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331630047X |
Similar Items
-
Fibronectin and androgen receptor expression data in prostate cancer obtained from a RNA-sequencing bioinformatics analysis
by: Dibash K. Das, et al.
Published: (2017-04-01) -
The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma
by: Shen ED, et al.
Published: (2016-06-01) -
Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis
by: Leire Moya, et al.
Published: (2019-03-01) -
PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
by: Adeodat Ilboudo, et al.
Published: (2015-12-01) -
Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
by: Lei You, et al.
Published: (2018-12-01)